切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2015, Vol. 12 ›› Issue (10) : 748 -752. doi: 10.3877/cma.j.issn.1672-6448.2015.10.002

所属专题: 文献

综述

甲状腺结节活检的临床应用进展
胡向东1, 钱林学1,()   
  1. 1. 100050 首都医科大学附属北京友谊医院超声科
  • 收稿日期:2015-08-31 出版日期:2015-10-01
  • 通信作者: 钱林学

Advances of thyroid nodule biopsy

Xiangdong Hu1, Linxue Qian1()   

  • Received:2015-08-31 Published:2015-10-01
  • Corresponding author: Linxue Qian
引用本文:

胡向东, 钱林学. 甲状腺结节活检的临床应用进展[J]. 中华医学超声杂志(电子版), 2015, 12(10): 748-752.

Xiangdong Hu, Linxue Qian. Advances of thyroid nodule biopsy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2015, 12(10): 748-752.

表1 甲状腺结节的超声评分系统
表2 甲状腺结节进行FNAB的适应证(2015 NCCN)
表3 甲状腺结节细胞学诊断Bethesda报告系统
[1]
于晓会, 单忠艳. 甲状腺结节的病因与流行病学趋势[J]. 中国普外基础与临床杂志, 2011, 18(8): 800-802.
[2]
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11): 1167-1214.
[3]
孙嘉伟, 许晓君, 蔡秋茂, 等. 中国甲状腺癌发病趋势分析[J]. 中国肿瘤, 2013, 22(9): 690-693.
[4]
Brito JP, Gionfriddo MR, Al Nofal A, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2014, 99(4): 1253-1263.
[5]
Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk [J]. Radiology, 2011, 260(3): 892-899.
[6]
Perros P, Boelaert K, Colley S, et al. British Thyroid Association. Guidelines for the management of thyroid cancer [J]. Clin Endocrinol (Oxf), 2014, 81( Suppl 1): 1-122.
[7]
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid carcinoma (2015).

URL    
[8]
Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations [J]. Endocr Pract, 2010, 16(3): 468-475.
[9]
中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华核医学与分子影像杂志, 2013, 33(4): 96-115.
[10]
Smith-Bindman R, Lebda P, Feldstein VA. et al. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study [J]. JAMA Internal Medicine, 2013, 173(19): 1788-1796.
[11]
Kamran SC, Marqusee E, Kim MI et al. Thyroid nodule size and prediction of cancer [J]. J Clin Endocrinol Metab. 2013, 98(2): 564-570.
[12]
Bonavita JA, Mayo J, Babb J. et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone [J]. AJR Am J Roentgenol, 2009, 193(1), 207-213.
[13]
Moon WJ, Baek JH, Jung SL, et al. Ultrasound and ultrasound based management of thyroid nodules: concensus statement and recommendations [J]. Korean J Radiol, 2011, 12(1): 1-14.
[14]
Popowicz B, Klencki M, Lewinski A, et al. The usefulness of sonographic features in selection of thyroid nodules for biopsy in relation to the nodule's size [J]. Eur J Endocrinol, 2009, 161(1): 103-111.
[15]
Cibas ES, Ali SZ, NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology [J]. Am J Clin Pathol, 2009, 132(5): 658-665.
[16]
Kim SY, Han KH, Moon HJ, et al. Thyroid nodules with benign findings at cytologic examination: results of long-term follow-up with US [J]. Radiology, 2014, 271(1): 272-281.
[17]
Yoon JH, Moon HJ, Kim EK, et al. Inadequate cytology in thyroid nodules: should we repeat aspiration or follow-up? [J]. Ann Surg Oncol, 2011, 18(5): 1282-1289.
[18]
Ha EJ, Baek JH, Lee JH, et al. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy [J]. Thyroid. 2013, (6); 23: 703-708.
[19]
Hakala T, Kholová I, Sand J, et al. A core needle biopsy provides more malignancy-specifi results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy [J]. J Clin Pathol, 2013, 66(12): 1046-1050.
[20]
Yoon JH, Kwak JY, Kim EK, et al. How to approach thyroid nodules with indeterminate cytology [J]. Ann Surg Oncol, 2010, 17(8): 2147-2155.
[21]
Ho AS, Sarti EE, Jain KS, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS) [J]. Thyroid, 2014, 24(5): 832-839.
[22]
Na DG, Kim JH, Sung JY, et al. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology [J]. Thyroid, 2012, 22(5): 468-475.
[23]
Choi SH, Han KH, Yoon JH, et al. Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules [J]. Clin Endocrinol (Oxf), 2011, 74(6): 776-782.
[24]
Izquierdo R, Arekat MR, Knudson PE, et al. Comparison of palpation-guided versus ultrasound-guided fine-needle aspiration biopsies of thyroid nodules in an outpatient endocrinology practice [J]. Endocrine Practice, 2006, 12(6): 609-614.
[25]
Stamataki M, Anninos D, Broantzos E, et al. The role of liquid-based cytology in the investigation of thyroid lesions [J]. Cytopathology, 2008, 19(1): 11-18.
[26]
Tulecke MA, Wang HH. ThinPrep for cytologic evaluation of follicular thyroid lesions: correlation with histologic findings [J]. Diagn Cytopathol, 2004, 30(1): 7-13.
[27]
李文波, 朱庆莉, 姜玉新, 等. 薄层液基细胞学涂片在超声引导下甲状腺细针抽吸活检的应用[J]. 协和医学杂志, 2014, 5(1): 8-12.
[28]
Afify AM, Liu J, At-Khafaji BM. Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep: a comparative retrospective review [J]. Cancer, 2001, 93(3): 179-186.
[29]
Trimboli P, Nasrollah N, Guidobaldi L, et al. The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fie-needle aspiration [J]. World J Surg Oncol, 2014, 12: 61.
[30]
Zhang M, Zhang Y, Fu S, et al. Thyroid nodules with suspicious ultrasound fidings: the role of ultrasound-guided core needle biopsy [J]. Clin Imaging, 2014, 38(4): 434-438.
[31]
Li L, Chen BD, Zhu HF, et al. Comparison of pre-operation diagnosis of thyroid cancer with fie needle aspiration and core-needle biopsy: a meta-analysis [J]. Asian Pac J Cancer Prev. 2014, 15(17): 7187-7193.
[32]
王蕾, 朱庆莉, 姜玉新, 等. 超声引导组织活检对甲状腺病变的诊断价值[J]. 协和医学杂志, 2014, 5(1): 13-16.
[33]
Choi SH, Baek JH, Lee JH, et al. Thyroid nodules with initially nondiagnostic, fie-needle aspiration results: comparison of core-needle biopsy and repeated fie-needle aspiration [J]. Eur Radiol, 2014, 24(11): 2819-2826.
[34]
Samir AE, Vij A, Seale MK, et al. Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fie-needle aspirate [J]. Thyroid, 2012, 22(5): 461-467.
[35]
Novoa E, Gurtler N, Arnoux A, et al. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature [J]. Head Neck, 2012, 34(10): 1497-1503.
[36]
Polyzos SA, Anastasilakis AD. Clinical complications following thyroid fine-needle biopsy: a systematic review [J]. Clin Endocrinol (Oxf). 2009, 71(2): 157-165.
[37]
Hor T, Lahiri SW. Bilateral thyroid hematomas after fineneedle aspiration causing acute airway obstruction [J]. Thyroid, 2008, 18(5): 567-569.
[38]
Veverková L, Bakaj-Zbrožková L, Hallamová L, et al. Computed tomography diagnosis of active bleeding into the thyroid gland [J]. Thyroid, 2013, 23(10): 1326-1328.
[39]
Cibas ES, Alexander EK, Benson CB, et al. Indications for thyroid FNA and pre-FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference [J]. Diagn Cytopathol, 2008, 36(6): 390-399.
[40]
Pitman MB, Abele J, Ali SZ, et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference [J]. Diagn Cytopathol, 2008, 36(6): 407-424.
[41]
Polyzos SA, Anastasilakis AD. A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy [J].World J Surg, 2010, 34(4): 844-851.
[42]
Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology [J]. N Engl J Med, 2012, 367(8): 705-715.
[43]
Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples [J]. J Clin Endocrinol Metab, 2011, 96(11): 3390-3397.
[44]
Musholt TJ, Fottner C, Weber MM, et al. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules [J]. World J Surg, 2010, 34(11): 2595-2603.
[45]
Nikiforova MN, Lynch RA, Biddinger PW, et al. AS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma [J]. J Clin Endocrinol Metab, 2003, 88(5): 2318-2326.
[46]
Alexander EK, Schorr M, Klopper J, et al. Multicenter clinical xperience with the Afirma gene expression classifier [J]. J Clin Endocrinol Metab, 2014, 99(1): 119-125.
[47]
Duick DS, Klopper JP, Diggans JC, et al. The impact of benign gene xpression classifier test results on the endocrinologist-patient decision o operate on patients with thyroid nodules with indeterminate fineneedle aspiration cytopathology [J]. Thyroid, 2012, 22(10): 996-1001.
No related articles found!
阅读次数
全文


摘要